Risk factors for drug-induced gingival overgrowth

被引:184
作者
Seymour, RA [1 ]
Ellis, JS [1 ]
Thomason, JM [1 ]
机构
[1] Univ Newcastle Upon Tyne, Sch Dent, Dept Restorat Dent, Newcastle Upon Tyne NE2 4BW, Tyne & Wear, England
关键词
drug-induced gingival overgrowth; risk factors; phenytoin; cyclosporin; calculus channel blocker;
D O I
10.1034/j.1600-051x.2000.027004217.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background/Aims: Drug-induced gingival overgrowth remains a significant problem for the periodontologist. Many patients medicated with the drugs implicated in this unwanted effect experience significant, recurrent gingival problems that, require repeated surgical excisions. In this review, we attempt to identify and quantify the Various "risk factors" associated with both the development and expression of the drug-induced gingival changes. Method: The risk factors appraised include age, sex, drug variables, concomitant medication, periodontal variables and genetic factors. Elucidation of such factors may help to identify "at risk patients" and then develop appropriate treatment strategies. Results: Of the factors identified, the only one that can be affected by the periodontologist is the patents' periodontal condition. However, drug variables and concomitant medication do impact upon the expression of gingival overgrowth. Conclusion: The identification of risk factors associated with both the prevalence and severity of drug-induced gingival overgrowth is important for all parties involved with this unwanted effect. Both periodontologist and patient have an important role to play in improving oral hygiene and gingival health. Likewise, there is always an opportunity to establish a close liaison between the patient's physician and the periodontologist to try and identify alternative drug regimens that can help reduce the impact of this unwanted effect.
引用
收藏
页码:217 / 223
页数:7
相关论文
共 68 条
  • [1] Allman Suzanne D., 1994, Pediatric Dentistry, V16, P36
  • [2] INCIDENCE OF DIPHENYLHYDANTOIN GINGIVAL HYPERPLASIA
    ANGELOPO.AP
    GOAZ, PW
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1972, 34 (06): : 898 - &
  • [3] GINGIVAL HYPERPLASIA + DILANTIN CONTENT OF SALIVA - PILOT STUDY
    BABCOCK, JR
    NELSON, GH
    [J]. JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1964, 68 (02) : 195 - &
  • [4] Ball DE, 1996, J PERIODONTOL, V67, P597
  • [5] THE INCIDENCE AND SEVERITY OF NIFEDIPINE-INDUCED GINGIVAL OVERGROWTH
    BARCLAY, S
    THOMASON, JM
    IDLE, JR
    SEYMOUR, RA
    [J]. JOURNAL OF CLINICAL PERIODONTOLOGY, 1992, 19 (05) : 311 - 314
  • [6] BOKENKAMP A, 1994, PEDIATR NEPHROL, V8, P181
  • [7] Evaluation of gingival and periodontal conditions following causal periodontal treatment in patients treated with nifedipine and diltiazem
    Bullon, P
    Machuca, G
    MartinezSahuquillo, A
    Rios, JV
    Velasco, E
    Rojas, J
    Lacalle, JR
    [J]. JOURNAL OF CLINICAL PERIODONTOLOGY, 1996, 23 (07) : 649 - 657
  • [8] CLINICAL-ASSESSMENT OF GINGIVAL SIZE AMONG PATIENTS TREATED WITH DILTIAZEM
    BULLON, P
    MACHUCA, G
    MSAHUQUILLO, A
    ROJAS, J
    LACALLE, JR
    RIOS, JV
    VELASCO, E
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1995, 79 (03): : 300 - 304
  • [9] Phenytoin-induced gingival overgrowth:: A community-based cross-sectional study in Ferrara, Italy
    Casetta, I
    Granieri, E
    Desiderá, M
    Monetti, VC
    Tola, MR
    Paolino, E
    Govoni, V
    Calura, G
    [J]. NEUROEPIDEMIOLOGY, 1997, 16 (06) : 296 - 303
  • [10] The effect of verapamil on the prevalence and severity of cyclosporine-induced gingival overgrowth in renal allograft recipients
    Cebeci, I
    Kantarci, A
    Firatli, E
    Carin, M
    Tuncer, O
    [J]. JOURNAL OF PERIODONTOLOGY, 1996, 67 (11) : 1201 - 1205